|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.76 SEK | -2.38% |
|
-0.10% | +4.92% |
| 13/06 | DNB Carnegie brokers 0.5 percent of shares in Vimian | FW |
| 13/06 | Vimian Group AB (OM:VIMIAN) signed an agreement to acquire AllAccem Inc. | CI |
| Capitalization | 197.04Cr 229.85Cr 183.21Cr 170.45Cr 314.8Cr 20TCr 349.81Cr 2.2TCr 840.38Cr 9.23TCr 862.06Cr 844.54Cr 34TCr | P/E ratio 2025 * |
46.7x | P/E ratio 2026 * | 30.2x |
|---|---|---|---|---|---|
| Enterprise value | 215.29Cr 251.14Cr 200.18Cr 186.24Cr 343.96Cr 22TCr 382.22Cr 2.41TCr 918.23Cr 10TCr 941.91Cr 922.77Cr 37TCr | EV / Sales 2025 * |
4.98x | EV / Sales 2026 * | 4.44x |
| Free-Float |
33.03% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Vimian Group AB
More recommendations
More press releases
More news
| 1 day | -2.38% | ||
| 1 week | -0.10% | ||
| Current month | +4.40% | ||
| 1 month | +0.29% | ||
| 3 months | +13.85% | ||
| 6 months | +12.71% | ||
| Current year | +4.92% |
| 1 week | 41.5 |  | 42.92 |
| 1 month | 38.82 | | 42.92 |
| Current year | 34.3 | | 47.3 |
| 1 year | 31.45 | | 47.3 |
| 3 years | 20.08 | | 47.3 |
| 5 years | 20.08 | | 123.4 |
| 10 years | 20.08 | | 123.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Patrik Eriksson
CEO | Chief Executive Officer | 57 | 01/01/2024 |
| Director of Finance/CFO | 46 | 01/01/2022 | |
| Investor Relations Contact | 44 | 01/09/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 48 | 01/01/2021 | |
Theodor Bonnier
BRD | Director/Board Member | 36 | 01/01/2021 |
Petra Rumpf
BRD | Director/Board Member | 58 | 01/01/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.38% | -0.10% | +17.63% | -7.20% | 230.43Cr | ||
| -2.42% | -2.65% | -13.45% | -10.85% | 6.9TCr | ||
| -0.93% | +1.78% | +7.89% | -25.46% | 740Cr | ||
| +0.62% | +1.34% | -8.41% | +5.49% | 366.64Cr | ||
| -1.16% | +1.04% | -5.28% | -7.46% | 333.97Cr | ||
| -1.09% | +10.00% | +76.20% | +58.76% | 124.84Cr | ||
| +1.34% | -0.30% | +48.27% | +13.31% | 124.69Cr | ||
| +0.52% | +2.09% | -20.65% | -36.38% | 107.6Cr | ||
| +1.35% | +2.87% | +10.09% | -36.72% | 107.26Cr | ||
| -0.06% | -0.81% | +21.66% | -36.02% | 103.22Cr | ||
| Average | -0.42% | +1.32% | +13.40% | -8.25% | 913.76Cr | |
| Weighted average by Cap. | -1.96% | -1.64% | -7.78% | -10.77% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 43Cr 50Cr 40Cr 37Cr 69Cr 4.33TCr 77Cr 483.07Cr 184.31Cr 2.02TCr 189.06Cr 185.22Cr 7.42TCr | 48Cr 55Cr 44Cr 41Cr 76Cr 4.77TCr 84Cr 531.2Cr 202.68Cr 2.23TCr 207.91Cr 203.68Cr 8.16TCr |
| Net income | 3.78Cr 4.41Cr 3.51Cr 3.27Cr 6.04Cr 379.03Cr 6.71Cr 42Cr 16Cr 177.01Cr 17Cr 16Cr 649.06Cr | 6.29Cr 7.34Cr 5.85Cr 5.44Cr 10Cr 630.83Cr 11Cr 70Cr 27Cr 294.61Cr 28Cr 27Cr 1.08TCr |
| Net Debt | 18Cr 21Cr 17Cr 16Cr 29Cr 1.83TCr 32Cr 204.03Cr 78Cr 854.83Cr 80Cr 78Cr 3.13TCr | 14Cr 16Cr 13Cr 12Cr 22Cr 1.39TCr 25Cr 155.44Cr 59Cr 651.25Cr 61Cr 60Cr 2.39TCr |
More financial data
* Estimated data
Employees
1,200
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/25/11 | 41.76 kr | -2.38% | 1,51,108 |
| 10/25/10 | 42.78 kr | +1.37% | 1,37,355 |
| 09/25/09 | 42.20 kr | -0.80% | 1,25,227 |
| 08/25/08 | 42.54 kr | +1.87% | 5,06,861 |
| 07/25/07 | 41.76 kr | -0.10% | 1,35,576 |
Delayed Quote Nasdaq Stockholm, July 11, 2025 at 09:30 pm IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
3.742EUR
Average target price
4.041EUR
Spread / Average Target
+8.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VIMIAN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition